Home Testing and validating a homogeneous immunometric assay for interference
Article
Licensed
Unlicensed Requires Authentication

Testing and validating a homogeneous immunometric assay for interference

  • Johan Bjerner , Kari Hauge Olsen , Ole P. Børmer and Kjell Nustad
Published/Copyright: June 1, 2005

Abstract

We analyzed 95 sera, demonstrating interference in a previous study, with the Kryptor homogeneous time-resolved fluorescence resonance energy transfer carcinoembryonic antigen (CEA) immunoassay (Brahms AG, Berlin, Germany). Only one serum differed, i.e., 6.0 μg/l for Kryptor vs. 13.3 μg/l for a microtiter plate in-house immunofluorometric assay (IFMA), using both aggregated mouse immunoglobulins as blocker and capture monoclonal antibody (Mab) F(ab′)2-fragments to reduce interference. Sera were further analyzed with experimental IFMAs with intact capture Mabs and without blocker. The Kryptor-CEA assay Mab GFR44 (capture) had elevated results in 71% of sera with the Kryptor Mab G15 (tracer) or in 81% with our tracer Mab. G15 (capture) had 65% elevated results with GFR44 (tracer) or 99% with our tracer Mab. The latter was reduced from 99% to 62% by adding Kryptor blocker to the buffer or to 30% by adding our blocker. Finally, combining both assay Mabs and assay buffer from Kryptor still gave interference in 16% of sera.

Kryptor-CEA assay results thus agreed with our inhouse CEA assay results, showing no interference. As the Kryptor-CEA assay antibodies were sensitive to interference and the Kryptor-CEA assay buffer did not reduce interference as efficiently as our in-house assay buffer, the Kryptor-CEA assay format was crucial for the absence of interference.

Published Online: 2005-6-1
Published in Print: 2004-2-18

Copyright (c) 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
  2. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
  3. Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
  4. Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
  5. Antioxidants in patients with hyperthyroidism
  6. Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
  7. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
  8. Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
  9. Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
  10. Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
  11. Diagnostic use of cerebral and extracerebral oxysterols
  12. Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
  13. The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
  14. Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
  15. Testing and validating a homogeneous immunometric assay for interference
  16. Linearity evaluation of analytical methods that count particles
  17. Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
  18. Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
  19. Distribution of low-density lipoprotein particle size in healthy Korean adult males
  20. Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
  21. The phenomenon of regression-toward-the-mean
  22. Error messages when calculating chi-square statistics with Microsoft EXCEL®
  23. Meetings and Awards
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.038/html
Scroll to top button